• Sanchita Ahluwalia Haffkine Institute of Training, Research & Testing Mailing address: 2001/2, Royale A Wing, Neelkanth Palms, Off Ghodbunder Road, Thane, Mumbai, Maharaashtra, India 400610
  • Nakul Shah Haffkine Institute of Training, Research & Testing Mailing address: 2001/2, Royale A Wing, Neelkanth Palms, Off Ghodbunder Road, Thane, Mumbai, Maharaashtra, India 400610


Breast cancer is one of the most common malignancies found in women and is associated with increased mortality in advanced disease. With the use of improved screening techniques and improvisation in treatment, 89% of the women diagnosed with breast cancer will survive 5 years from diagnosis. Despite significant advancement in the diagnosis and treatment of breast cancer, many patients succumb to this disease. The elucidation of aberrant signaling pathways that lead to breast cancer should help develop more effective therapeutic strategies. This review focuses on the different targets of breast cancer and how they can be acted upon by different animal venoms.


Keywords: Breast, Cancer, Target, Venom.


Download data is not yet available.


1. Freddie Bray, Jian-Song Ren, Eric Masuyer, Jacques Ferlay. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133–45.
2. Huang W, Seo J, Willingham SB, Czyzewski AM, Gonzalgo ML, et al. Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity. PLoS ONE 2014;9(2): e903-97.
3. Pan H, Soman NR, Schlesinger PH, Lanza GM, Wickline SA. Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy. Wiley Interdiscip Rev: Nanomed Nanobiotechnol 2011;3:318–27.
4. Park MH, Jo MR, Won D, et al. Snake venom toxin from Vipera lebetina turanica induces apoptosis in colon cancer cells via upregulation of ROS-and JNK-mediated death receptor expression. BMC Cancer 2012;12(1):228.
5. Song JK, Jo MR, Park MH, et al. Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor κB and signal transducer and activator of transcription 3. Arch Pharm Res 2012;35(5):867-76.
6. Zhang XJ, et al. Development, characterization and anti-tumor effect of a sequential sustained-release preparation containing ricin and cobra venom cytotoxin. Pharmazie 2012;67(7):618-21.
7. Ye B, et al. Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549. Acta Pharmacol Sin 2011;32(11):1397-401.
8. Di Lorenzo L, Palmieri Chiara, Cusano Antonio, Foti Calogero. Cancer pain managment with a venom of blue scorpion endemic in cuba, called rhopalurus junceus “ Escozul”. Open Cancer J 2012;5:1-2.
9. Adam N Mamelak, Steven Rosenfeld, Richard Bucholz, et al. Phase i single-dose study of intracavitary-administered iodine-131-tm-601 in adults with recurrent high-grade glioma. JCO 2006;24(22):3644-50.
10. Ning YN, Zhang WD, Wu LC. Study on the mechanism of polypeptide extract from scorpion venom to promote the restraint of cyclophosphamide on Lewis lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012;32(4):537-42.
11. Huang WW, et al. Bufalin induces G(0)/G(1) phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells. Mutat Res 2012;732(1-2):26-33.
12. Qi F, et al. Induction of apoptosis by cinobufacini preparation through mitochondria-and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells. Food Chem Toxicol 2012;50(2):295-302.
13. Badr G, Garraud O, Daghestani M, Al-Khalifa MS, Richard Y. Human breast carcinoma cells are induced to apoptosis by samsum ant venom through an IGF-1-dependant pathway, PI3K/AKT and ERK signalling. Cell Immunol 2012;273(1):10-6.
14. Ellin JM, Batz F, Hitchens K. Natural medicines comprehensive database. stockton, ca: Therapeutic Res Faculty 2005:103–4, 681–3, 1034–5, 1088–9.
15. Oršolić N. Bee venom in cancer therapy. Cancer Metastasis Rev 2012;31(1-2):173-94.
16. G Davies, L A Martin, N Sacks, M Dowsett. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol 2002;13:669–78.
17. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3(4):276-85.
18. Nam KW, Je KH, Lee JH, Han HJ, Lee HJ, Kang SK, Mar W. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Arch Pharm Res 2003;26(5):383-8.
19. Serdar E Bulun. Aromatase excess in cancers of breast, endometrium and ovary, J Steroid Biochem Mol Biol 2007;106(1-5):81–96.
20. C J Fabian. The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. Int J Clin Pract 2007;61(12):2051–63.
21. Ajay S, Bhatnagar. The discovery and mechanism of action of letrozole. Breast Cancer Res Treat 2007;105:7–17.
22. Goran Gajski, Vera Garaj-Vrhovac. Melittin: a lytic peptide with anticancer properties. Environ Toxicol Pharmacol 2013;36(2):697-705.
23. Lin Show Whei. Arachidonic acid as a potential intracellular regulator of aromatase activity in human term trophoblast, Unpublished master's thesis for master's degree University of British Columbia, Canada
24. Lien Ai Pham-Huy, Hua He, Chuong Pham-Huy, Free Radicals. Antioxidants in disease and health. Int J Biomed Sci 2008;4(2):89–96.
25. Solange Teresinha Carpes, Rosicler Begnini, Severino Matias de Alencar, Maria Lúcia Masson. Study of preparations of bee pollen extracts, antioxidant and antibacterial activity. Ciênc Agrotec Lavras 2007;31(6):1818-25.
26. Gomase VS, Phadnis AC, Ghatak AA. Immunoproteomics approach for prediction of antigenic epitope of Tertiapin from Apis mellifera. Int J Drug Disc 2009;1(1):14-7.
27. Paul Bevan Carola Mala. The role of uPA and uPA inhibitors in breast cancer. Breast Care 2008;3(2):1–2.
28. Ming Zhang, Jeremy S Schaefer. Hypoxia effects: implications for maspin regulation of the uPA/uPAR complex. Cancer Biol Ther 2005;4(9):1033-5.
29. Chatri Ngamkitidechakul, et al. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. J Biol Chem 2003;278(34):31796–806.
30. Raghuraman H, Amitabha Chattopadhyay. Melittin: a membrane-active peptide with diverse functions. Biosci Rep 2007;27(4-5):189-23.
31. Al-Sadoon MK, Abdel-Maksoud MA, Rabah DM, Badr G. Induction of apoptosis and growth arrest in human breast carcinoma cells by a snake (walterinnesia aegyptia) venom combined with silica nanoparticles: crosstalk between bcl2 and caspase 3. Cell Physiol Biochem 2012;30(3):653-65.
32. Lin KL, Chien CM, Hsieh CY, Tsai PC, Chang LS, Lin SR. Antimetastatic potential of cardiotoxin III involves inactivation of PI3K/Akt and p38 MAPK signaling pathways in human breast cancer MDA-MB-231 cells. Life Sci 2012;90(1-2):54-65.
33. Carey CM, Bueno R, Gutierrez DA, Petro C, Lucena SE, Sanchez EE, Soto JG. Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28. Toxicon 2012;59(2):241-8.
34. Robert Finn. Snake Venom Protein Paralyzes Cancer Cells. J Natl Cancer Inst 2001;93(4):261-2.
35. Din Muhammad Shaikh, Rukhsana Jokhio. In vitro crude cobra snake venom significantly decreases the production of rna & dna in breast cancerous tissue. Pak J Physiol 2006;2(1).
36. B V LIPPS. Novel snake venom proteins cytolytic to cancer cells in vitro and in vivo systems. J Venom Anim Toxins 1999;5(2).
37. Anindita Debnath, et al. Venom of Indian monocellate cobra and Russell’s viper show anticancer activity in experimental models. J Ethnopharmacol 2007;111(3):681-4.
38. Rebecca D Pierce, et al. Characterization of crude Echis carinatus venom-induced cytotoxicity in HEK 293T cells. J Venom Res 2011;2:59-67.
39. D C I Koh, A Armugam, K Jeyaseelan. Snake venom components and their applications in biomedicine. Cell Mol Life Sci 2006;63:3030–41.
40. Alexei V. Feofanov, et al. Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage. Biochem J 2005;390:11–8.
41. Ravi Kant Upadhyay. Animal proteins and peptides: Anticancer and antimicrobial potential. J Pharm Res 2010;3(12):3100-8.
42. D'Suze G, Rosales A, Salazar V, Sevcik C. Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line, Toxicon 2010;56(8):1497-505.
43. Zargan J, et al. Scorpion venom (Odontobuthus doriae) induces apoptosis by depolarization of mitochondria and reduces S-phase population in human breast cancer cells (MCF-7). Toxicol In Vitro 2011;25(8):1748-56.
44. Tiago Elias Heinen, Ana Beatriz Gorini da Veiga. Arthropod venoms and cancer. Toxicon 2011;57(4):497–511.
45. Liu Z, Zhao Y, Li J, Xu S, Liu C, Zhu Y, Liang S. The venom of the spider Macrothele raveni induces apoptosis in the myelogenous leukemia K562 cell line. Leuk Res 2012;36(8):1063-6.
46. A M Bajo, A V Schally, K Groot, K Szepeshazi. Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers. Br J Cancer 2004;90(1):245–52.
47. Saeid Ghavami, et al. Brevinin-2R 1 semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med 2008;12(3):1005-22.
48. Noriyuki Takai, et al. Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells. Asian Pacific J Cancer Prev 13:399-402.
49. Anjoo Kamboj, Aarti Rathour, Mandeep Kaur. Bufadienolides and their medicinal utility: a review. Int J Pharm Pharm Sci 2013;5(4):20-7.
50. Lia Hafiyani, Satoru Yokoyama, Sherif Abdelhamed, Yoshihro Hayakawa, Ikuo Saiki. Bufadienolides overcome trail resistance in breast cancer cells via jak-stat pathway. Altern Integ Med 2014;3:2.
691 Views | 1362 Downloads
How to Cite
Ahluwalia, S., and N. Shah. “ANIMAL VENOM FOR TREATING BREAST CANCER”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 6, no. 9, 1, pp. 24-30,
Review Article(s)